Chart of the month

Tue Jun 1, 2004

CCL Fund

Castle Creek Lifescience Partners' CCL Fund has considerably outperformed both the NASDAQ and the Absolute Return Tech index by using

ISSN: 2151-1845 / CDC10004H


By registering you will receive

  • A monthly newsletter on your specified areas of interest
  • A fortnightly update on the sector

Free Trial

Take a trial today and access

  • Performance news, fund launches, regulation changes and people moves
  • Profiles of fund managers, investors and distributors
  • Live league tables
  • Investor mandates

Popular Searches on HFI